Charles Schwab’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9K | Sell |
14,484
-94,740
| -87% | -$235K | ﹤0.01% | 3470 |
|
|
2025
Q1 | $169K | Hold |
109,224
| – | – | ﹤0.01% | 3280 |
|
|
2024
Q4 | $234K | Hold |
109,224
| – | – | ﹤0.01% | 3299 |
|
|
2024
Q3 | $475K | Buy |
109,224
+7,021
| +7% | +$30.5K | ﹤0.01% | 3174 |
|
|
2024
Q2 | $476K | Buy |
102,203
+87,719
| +606% | +$409K | ﹤0.01% | 3215 |
|
|
2024
Q1 | $73.4K | Hold |
14,484
| – | – | ﹤0.01% | 3334 |
|
|
2023
Q4 | $40.7K | Hold |
14,484
| – | – | ﹤0.01% | 3420 |
|
|
2023
Q3 | $41.6K | Hold |
14,484
| – | – | ﹤0.01% | 3421 |
|
|
2023
Q2 | $73.1K | Buy |
+14,484
| New | +$73.1K | ﹤0.01% | 3372 |
|
|
2022
Q3 | – | Sell |
-17,994
| Closed | -$45K | – | 3511 |
|
|
2022
Q2 | $45K | Sell |
17,994
-30,293
| -63% | -$75.8K | ﹤0.01% | 3404 |
|
|
2022
Q1 | $134K | Sell |
48,287
-12,026
| -20% | -$33.4K | ﹤0.01% | 3371 |
|
|
2021
Q4 | $322K | Hold |
60,313
| – | – | ﹤0.01% | 3269 |
|
|
2021
Q3 | $511K | Sell |
60,313
-58,270
| -49% | -$494K | ﹤0.01% | 3144 |
|
|
2021
Q2 | $1.45M | Buy |
118,583
+4,077
| +4% | +$49.7K | ﹤0.01% | 2811 |
|
|
2021
Q1 | $2.78M | Buy |
114,506
+6,379
| +6% | +$155K | ﹤0.01% | 2555 |
|
|
2020
Q4 | $3.47M | Buy |
108,127
+1,558
| +1% | +$49.9K | ﹤0.01% | 2391 |
|
|
2020
Q3 | $3.22M | Buy |
106,569
+25,314
| +31% | +$765K | ﹤0.01% | 2301 |
|
|
2020
Q2 | $3.43M | Buy |
81,255
+55,702
| +218% | +$2.35M | ﹤0.01% | 2204 |
|
|
2020
Q1 | $638K | Buy |
+25,553
| New | +$638K | ﹤0.01% | 2628 |
|